Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 355

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 355
---
 in a trio format that includes samples of the patient’s biological parents. This test is appropriate for preconception, neonatal, childhood, and adult patients, particularly those with rare Mendelian diseases or conditions with significant genetic heterogeneity and overlapping or nonspecific phenotypes. In addition, secondary findings are reported by request. Microbiome: Gut Screening Test This screening test tracks 28 selected biomarkers in the gut microbiome from relevant ecological metrics such as diversity, richness and balance to insightful metabolic capacity metrics such as short chain fatty acids production, vitamins production, Lipopolysaccharides production and other metrics related to the influence of gut microbiome in low grade chronic inflammation process. The test compares the patient’s metrics to our proprietary database of reference individuals who have healthy habits to identify potential dysbiosis processes. This allows gastroenterologists and related physicians to identify and monitor progress in treatments and conditions. Commercial Operations We currently offer our Heritas products in Argentina and Paraguay, while our Rewell products are available in Argentina. We expect to increase our business development initiatives and the offering of our services to Mexico and the rest of Latin America through partnerships and the development of the strategic consortium. Rewell Commercial Operations Rewell is marketed as a brand that offers preventative health solutions, available through select laboratories, nutrition centers and direct -to -consumer(DTC) channels. Samples collected through these channels are shipped to our Argentine Wet -Labfor processing. By combining a strong digital presence — including our proprietary e -commercewebsite and web application — with physical locations, Rewell engages with customers and facilities both B2B2C and DTC sales. Rewell’s platform provides DNA and microbiome testing kits, along with personalized recommendations tailored to individual needs and habits. To build Rewell’s brand awareness as a leader in wellness and prevention, we leverage digital marketing strategies, including social media advertising, influencer partnerships, content marketing, and search engine marketing. These efforts target health -consciousindividuals concerned with specific health conditions, aging, physical performance, and long -termwellness. Most of our customers are between the ages of 25 to50, of which 50% are men, and 50% are women. This approach has also attracted select laboratories, nutrition centers and nutritionists interested in commercializing. Rewell’s kits over -the -counter. These partners bring Rewell’s solutions to through their physical locations, where they can connect directly with their own health -consciousclients, offering a convenient way for customers to access our services. Additionally,